LACK OF CLINICALLY SIGNIFICANT INVITRO AND INVIVO INTERACTIONS BETWEEN RANITIDINE AND SUCRALFATE

被引：18
|
作者：
MULLERSMAN, G [1 ]
GOTZ, VP [1 ]
RUSSELL, WL [1 ]
DERENDORF, H [1 ]
机构：
[1] UNIV FLORIDA,J HILLIS MILLER HLTH CTR,COLL PHARM,GAINESVILLE,FL 32610
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1986年 / 75卷 / 10期
关键词：
D O I：
10.1002/jps.2600751018
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：995 / 998
页数：4
相关论文
共 50 条
  • [31] Lack of cisplatin-ranitidine interactions in children.
    Ito, S
    Weitzman, S
    Klein, J
    Greenberg, M
    Lau, R
    Atanakovic, G
    Koren, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 193 - 193
  • [32] Clinically significant drug interactions with SSRIs
    Reactions Weekly, 1998, 683 (1) : 2 - 2
  • [33] Drug Interactions with TriptansWhich are Clinically Significant?
    Paul E. Rolan
    CNS Drugs, 2012, 26 : 949 - 957
  • [34] Clinically significant drug interactions in dermatology
    Barranco, VP
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (04) : 599 - 612
  • [35] LACK OF SIGNIFICANT DRUG INTERACTIONS BETWEEN EZETIMIBE AND TACROLIMUS IN HEALTHY SUBJECTS
    Oswald, S.
    Borgwardt, L.
    Nassif, A.
    Modess, C.
    Luetjohann, D.
    Siegmund, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S84 - S84
  • [36] Lack of Significant Drug Interactions Between Ezetimibe and Tacrolimus in Healthy Subjects
    Oswald, Stefan
    Borgwardt, Luisa
    Nassif, Ali
    Modess, Christiane
    Luetjohann, Dieter
    Siegmund, Werner
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 525 - 525
  • [37] Lack of a Clinically Significant Pharmacokinetic Interaction Between Pregabalin and Thioctic Acid in Healthy Volunteers
    Rhee, Su-jin
    Lee, Howard
    Ahn, Li Young
    Lim, Kyoung Soo
    Yu, Kyung-Sang
    CLINICAL THERAPEUTICS, 2018, 40 (10) : 1720 - 1728
  • [38] LACK OF MUTAGENIC ACTIVITY OF ADEMETIONINE INVITRO AND INVIVO
    PEZZOLI, C
    GALLIKIENLE, M
    STRAMENTINOLI, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (07): : 826 - 829
  • [39] A LACK OF PHARMACOKINETIC INTERACTION BETWEEN RANITIDINE AND PIROXICAM
    DIXON, JS
    LACEY, LF
    PICKUP, ME
    LANGLEY, SJ
    PAGE, MC
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) : 583 - 586
  • [40] Lack of clinically significant hepatotoxicity following moxifloxacin therapy
    Haverstock, D
    Choudhri, S
    PHARMACOTHERAPY, 2004, 24 (10): : 1441 - 1441
12345